Funding for high-risk multi-center therapeutic clinical trials (U01) from NIDDK in diabetes, digestive, and kidney diseases
NIDDK invites investigator-initiated U01 applications for hypothesis-driven, high-risk, multi-center therapeutic clinical trials on diabetes, digestive/nutritional/obesity, kidney, urologic, or hematologic diseases. Trials must test clinical safety, tolerability, efficacy or effectiveness (not mechanistic or observational), include a complete protocol at submission, and plan for diverse U.S. r…
This NOFO invites applications for investigator-initiated, high-risk multi-center therapeutic clinical trials conducted at one or more clinical centers. A multi-center study is classified as “high risk” if it utilizes either a high-risk intervention or has high operational risk, or both. NOT-DK-…
Funding Source
Eligibility
Foreign/Non-domestic entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Required registrations (must be completed be…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers